We then assessed the relationships to Braak NFT stage and Thal Aβ stage as measures of global brain Alzheimer’s neuropathological changes and to the parietal cortex percentage area of immunoreactivity for tau and Aβ as local measures of AD neuropathology in cortex overlying the PARWM. The gene discussed is MAPT; the disease is Alzheimer disease.